Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.

Neurology Today in 5

Neurology Today

Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders

FEB 12, 20244 MIN
Neurology Today in 5

Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders

FEB 12, 20244 MIN

Description

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.